Morgan Stanley’s Cabaletta Bio CABA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.01M Sell
1,324,806
-384,082
-22% -$584K ﹤0.01% 4698
2025
Q1
$2.37M Buy
1,708,888
+269,723
+19% +$374K ﹤0.01% 4493
2024
Q4
$3.27M Buy
1,439,165
+610,336
+74% +$1.39M ﹤0.01% 4331
2024
Q3
$3.91M Buy
828,829
+533,320
+180% +$2.52M ﹤0.01% 4150
2024
Q2
$2.21M Sell
295,509
-590,195
-67% -$4.41M ﹤0.01% 4498
2024
Q1
$15.1M Buy
885,704
+110,938
+14% +$1.89M ﹤0.01% 2982
2023
Q4
$17.6M Buy
774,766
+552,749
+249% +$12.5M ﹤0.01% 3455
2023
Q3
$3.38M Buy
222,017
+14,656
+7% +$223K ﹤0.01% 4016
2023
Q2
$2.68M Buy
207,361
+5,005
+2% +$64.6K ﹤0.01% 4230
2023
Q1
$1.67M Buy
202,356
+2,201
+1% +$18.2K ﹤0.01% 4566
2022
Q4
$1.85M Buy
200,155
+30,735
+18% +$284K ﹤0.01% 4516
2022
Q3
$110K Buy
169,420
+47,520
+39% +$30.9K ﹤0.01% 6028
2022
Q2
$129K Buy
121,900
+22,003
+22% +$23.3K ﹤0.01% 6135
2022
Q1
$203K Buy
99,897
+49,326
+98% +$100K ﹤0.01% 5919
2021
Q4
$191K Sell
50,571
-29,347
-37% -$111K ﹤0.01% 6098
2021
Q3
$972K Sell
79,918
-29,291
-27% -$356K ﹤0.01% 5058
2021
Q2
$940K Buy
109,209
+85,531
+361% +$736K ﹤0.01% 5113
2021
Q1
$263K Sell
23,678
-10,384
-30% -$115K ﹤0.01% 5496
2020
Q4
$425K Sell
34,062
-11,282
-25% -$141K ﹤0.01% 5178
2020
Q3
$492K Buy
45,344
+8,357
+23% +$90.7K ﹤0.01% 4654
2020
Q2
$412K Buy
36,987
+31,386
+560% +$350K ﹤0.01% 4699
2020
Q1
$41K Sell
5,601
-4,729
-46% -$34.6K ﹤0.01% 5543
2019
Q4
$144K Buy
+10,330
New +$144K ﹤0.01% 5531